#South Korea #Seoul #blood pressure #Sky Labs #Cart

The Innovative CART Blood Pressure Monitor

In a groundbreaking presentation at the ESC Congress 2026 in Munich, Sky Labs, led by CEO Jack ByungHwan Lee, unveiled the latest clinical research findings on the CART blood pressure monitor, a ring-type device designed to effectively monitor blood pressure for patients with atrial fibrillation (AF) and heart failure (HF). This device promises to revolutionize patient care by providing accurate, continuous blood pressure measurements.

Clinical Significance of CART

During the congress, several expert sessions were held to present data that highlighted CART's numerous advantages in patient management. Professor Ki-Hong Lee from Chonnam National University Hospital showcased a 24-hour blood pressure monitoring study in AF patients. He emphasized that "the CART monitor achieved a data usability rate of approximately 80%, significantly demonstrating the benefits of continuous, hourly measurement via a wearable, medical-grade ring, enabling precise observations of nighttime blood pressure drops."

In another session, Professor In-Cheol Kim of Keimyung University Dongsan Hospital reported robust findings on patients with severe heart failure, noting a high concordance between CART and conventional ambulatory blood pressure measurements (MAPA/ABPM) over a 24-hour period. His analysis confirmed that the CART device meets the European Society of Hypertension's strict error margins, substantiating its reliability for personalized heart failure management.

The CART monitor emerges as an essential tool for continuous blood pressure surveillance, especially in cases where traditional cuffs fail due to arrhythmia or pronounced fluctuations in readings.

Noteworthy Clinical Evidence

Several additional compelling conclusions were presented by prominent cardiologists. Professor Hae-Young Lee from Seoul National University Hospital reaffirmed CART's high measurement accuracy, aligning with the ESH's guidelines for cuffless devices through various testing protocols.

In a pertinent case study discussed by Professor Eun-Mi Lee from Dongguk University Ilsan Hospital, the use of the CART monitor allowed for the safe adjustment and reduction of a patient’s medication due to the device’s accurate feedback under cuff-related anxiety conditions. This highlights the potential for personalized treatment adjustments based on real-time data.

The research also extended to patients suffering from sleep apnea, led by Professor Jong-Chan Youn of Seoul St. Mary's Hospital, who examined over 12,000 respiratory events in 62 subjects and noted significant immediate blood pressure spikes post-recovery from apnea episodes.

Addressing Crucial Needs in Healthcare

Sky Labs stands out as one of the few companies adhering strictly to the ESH's validation criteria for cuffless measurement devices. Featuring advanced PPG sensors and deep learning algorithms, the CART monitor can provide 24-hour blood pressure readings from a simple finger-worn ring.

This technological achievement has already facilitated over 300,000 prescriptions across more than 2,000 medical institutions in Korea, demonstrating significant market acceptance. For the first time globally, it has also been included in the clinical guidelines of the Korean Society of Hypertension (6th edition).

Jack ByungHwan Lee remarked, "At ESC Congress 2026, we showcased CART's full potential to address complex cardiovascular conditions like AF and HF. With the impressive uptake seen from 300,000 prescriptions and inclusion in clinical protocols, we are poised to accelerate our expansion into European and global markets."

About Sky Labs

Founded in September 2015, Sky Labs specializes in health technology, developing and managing CART, a medical-grade ring and platform for monitoring patients with chronic conditions. In 2023, they received medical approval for the CART BP pro and achieved recognition from the Health Insurance Review and Assessment Service (HIRA) for its ambulatory blood pressure measurement services. The company continues to expand its reach, offering the CART BP version to the public through diverse distribution channels and its official online store.

For further information and media inquiries, contact:

• - Inok Jung - [email protected]
• - Bomi Lee - [email protected]

Disclaimer: The CART blood pressure monitor is a prescription medical device intended for use under the supervision of healthcare professionals. Any modifications to medication or treatment plans must be conducted with qualified healthcare guidance.